ArticleSurgical endoscopy2026
Feasibility and perioperative safety of robotic liver resection using the da Vinci SP system: early single-center case series.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundClinical evidence for robotic liver resection (RLR) using the da Vinci SP™ system remains limited, particularly regarding perioperative outcomes during early implementation. We report an early single-center case series of RLR using the da Vinci SP system, primarily performed with a single-port (SP) -plus-one approach.
methodsThis retrospective study included consecutive patients who underwent RLR using the da Vinci SP system at a single institution. Prespecified safety endpoints were conversion, intraoperative transfusion, major complications (Clavien-Dindo grade ≥ IIIa), bile leakage, posthepatectomy liver failure (PHLF), posthepatectomy hemorrhage (PHH), readmission, and 30-day mortality. Bile leakage, PHLF, and PHH were defined according to International Study Group of Liver Surgery criteria. Operative metrics, postoperative stay, and margin status were also assessed.
resultsBetween October 2024 and December 2025, 20 patients underwent RLR using the da Vinci SP system. Median age was 74 years (range, 25-87), tumor size was 1.9 cm (range, 0.8-11.0), and Iwate difficulty score was 5 (range, 2-11). An SP-plus-one approach was used in 17 cases, whereas a true SP approach was used in 3. Anatomical resection was performed in eight patients, including four hemihepatectomies. No conversions or intraoperative transfusions were required. One patient experienced a major complication (duodenal ulcer bleeding requiring endoscopic hemostasis). No bile leakage, PHLF, PHH, readmissions, or 30-day mortality occurred. Median operative time was 283 min (range, 123-575), estimated blood loss was 33 mL (range, 5-200), and postoperative stay was 7.5 days (range, 4-11). R0 resection was achieved in all malignant cases.
conclusionsIn this early single-center case series, RLR using the da Vinci SP system was feasible in carefully selected patients, with no apparent increase in perioperative risk. These findings are descriptive and hypothesis-generating; larger multicenter prospective studies are warranted to define the clinical value and optimal role of the da Vinci SP in hepatobiliary surgery.
Indexed as
Identifiers
42387007What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.